Your session is about to expire
← Back to Search
Clinical Decision Support System for HIV Prevention (PrEDICT Trial)
PrEDICT Trial Summary
This trial will test whether an electronic health record (EHR)-based clinical decision support system that incorporates an HIV risk prediction model can help providers identify patients at increased risk for HIV infection and improve PrEP prescribing in safety-net community health centers.
PrEDICT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PrEDICT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a licensed provider who can prescribe PrEP at a participating clinic.N/A
- Group 1: Arm 1 - Standard of care
- Group 2: Arm 2 - Clinical decision support for PrEP
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment still open in this research endeavor?
"Affirmative. The details published on clinicaltrials.gov demonstrate that this medical trial is still taking applications; it was initially posted on July 11th 2022 and last updated on August 2nd 2022. In total, 4 participants are needed from three separateclinical sites."
How many participants are receiving treatment as part of this experiment?
"Affirmative. According to information available on clinicaltrials.gov, this experiment is actively searching for participants and began recruiting on July 11th 2022 with the last update taking place on August 2nd 2022. At present, 4 people need to be enrolled from 3 distinct healthcare sites."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger